Melatonin protects against lipid peroxidation and membrane rigidity in erythrocytes from patients undergoing cardiopulmonary bypass surgery

Journal of Pineal Research

Volumn 35, Issue 2, 2003, Pages 104-108

  Ochoa, Julio J ^a   Vílchez, María J ^b   Palacios, Miguel A ^b   García, Joaquín J ^c   Reiter, Russel J ^d   Muñoz Hoyos, Antonio ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b 'San Cecilio' Universitary Hospital   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cardiopulmonary bypass; Erythrocyte; Lipid peroxidation; Melatonin; Membrane fluidity; Thiobarbituric acid reactive substances (TBARS)

Indexed keywords

ASCORBIC ACID; FERROUS ION; MELATONIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; HEART SURGERY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MEMBRANE FLUIDITY; PINEAL BODY; SURGICAL PATIENT;

ANTIOXIDANTS; CELL MEMBRANE; CORONARY ARTERY BYPASS; ERYTHROCYTES; HUMANS; LIPID PEROXIDATION; MELATONIN; MEMBRANE FLUIDITY; MIDDLE AGED;

EID: 0042591064     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2003.00061.x     Document Type: Article

References (38)

1. HANNAN EL, KILBURN H, O'DONNELL JF, LUKACIK G, SHIELDS E. Adult open heart surgery in New York State. An analysis of risk factors and hospital mortality rates. JAMA 1990; 264:2768-2773.
2. ROMANOFF ME, KINGSLEY CP. Anesthetic management in the precardiopulmonary by-pass period. In: A Practical Approach to Cardiac Anaesthesia, Second Edition. Hensley FA, Martin DE, eds, Little Brown, Boston, 1995; pp. 219-230.
3. STARKOPF J, TAMME K, ZILMER M, TALVIK R, SAMARUTEL J. The evidence of oxidative stress in cardiac surgery and septic patients: a comparative study. Clin Chim Acta 1997; 262:77-88.
4. BOLLI R. Oxygen-derived free radicals and myocardial reperfusion injury - an overview. Cardiovasc Drugs Ther 1991; 262:249-268.
5. VAAGE J, VALEN G. Physiology and mediators of ischaemia-reperfusion injury with special reference to cardiac surgery. Scand J Thor Cardiovasc Surg 1993; 41 Suppl: 1-18.
6. JEROUDI MO, HARTLEY CJ, BOLLI R. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol 1994; 73:2B-7B.
7. GRACE PA. The injury caused by the sequence ischaemia reperfusion. Scand J Thor Cardiovasc Surg 1995; 29:175-180.
8. HENRY LE. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998; 66 Suppl:12-16.
9. REITER RJ, TAN DX. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res, 2003; 58:10-19.
10. HALLIWELL B, GUTTERIDGE JMC, CROSS CE. Free radical, antioxidants, and human disease: where are we now? J Lab Clin Med 1992; 119:598-620.
11. REITER RJ, TANG L, GARCIA JJ, MUNOZ-HOYOS A. Pharmacological actions of melatonin in free radical pathophysiology. Life Sci 1997; 60:2255-2271.
12. DOBRETSOV GE, BORSCHEVSKAYA TB, PETROV VA, VLADIMIROV YA. The increase of phospholipid bilayer rigidity after lipid peroxidation. FEBS lett 1977; 84:125-128.
13. CHEN JJ, YU BP. Alterations in mitochondrial membrane fluidity by lipid peroxidation products. Free Radic Biol Med 1994; 17:411-418.
14. SHINITZKY M. Membrane fluidity and cellular functions. In: Physiology of Membrane Fluidity, Vol 1. Shinitzky M, ed., CRC Press, Boca Raton, 1984; pp. 1-51.
15. REITER J, TAN DX, MANCHESTER LC, QI W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001; 34:247-256.
16. REITER RJ. Melatonin: lowering the high price of free radicals. News Physiol Sci 2000; 15:246-250.
17. ALLEGRA M, REITER RJ, TAN DX, GENTILE C, TESORIERE L, LIVREA MA. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34:1-10.
18. TAN DX, MANCHESTER LC, HARDELAND R et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003; 34:75-78.
19. MARTIN V, SAINZ RM, ANTOLIN I, MAYO JC, HERRERA F, RODRIQUEZ C. Several antioxidant pathways are involved in astrocyte protection by melatonin. J Pineal Res 2002; 33:204-212.
20. OKATANI Y, WAKATSUKI A, KANEDA C. Melatonin increases activities of glutathione peroxidase and superoxide dismutase in fetal rat brain. J Pineal Res. 2000; 28:89-96.
21. REITER RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56:359-384.
22. CUZZOCREA S, REITER RJ. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol 2001; 426:1-10.
23. SAHNA E, ACET A, OZER MK, OLMEZ E. Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supplemental physiological and pharmacological doses of melatonin. J Pineal Res 2002; 33:234-238.
24. GARCIA JJ, REITER RJ, GUERRERO JM et al. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997; 408:297-300.
25. SHIDA CS, CASTRUCCI AML, LAMY-FREUND MT. High melatonin solubility in aqueous medium. J Pineal Res 1994; 48:635-641.
26. PETTIGREW RA, HILL GL. Indicators of surgical risk and clinical judgement. Br J Surg 1986; 73:47-51.
27. HANAHAN DJ, EKHOLM JE. The preparation of red cell ghosts (membranes). Methods Enzymol 1974; 31:168-172.
28. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RG. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193:265-275.
29. GARRIDO A, GARRIDO F, GUERRA R, VALENZUELA A. Ingestion of high doses of fish oil increases the susceptibility of cellular membranes to the induction of oxidative stress. Lipids 1989; 24:833-835.
30. RICE-EVANS CA, DIPLOCK AT, SYMONS MCR. Techniques in Free Radical Research. In: Laboratory Techniques in Biochemistry and Molecular Biology. Burdon RH, Knippenberg PH, eds, Elservier Science Publishers, Amsterdam, 1991.
31. GARCÍA JJ, REITER RJ, PIÉ J et al. Role of pinoline and melatonin in stabilizing hepatic microsomal membranes against oxidative stress. J Bioenerg Biomembr 1999; 31:609-616.
32. HARDELAND R, POEGGELER B, NIEBERGALL R, ZELOSKO V. Oxidation of melatonin by carbonate radicals and chemiluminescence emitted during pyrrole ring cleavage. J Pineal Res 2003; 34:17-25.
33. GARCÍA JJ, REITER RJ, CABRERA J et al. 5-methoxytryptophol preserves hepatic microsomal membrane fluidity during oxidative stress. J Cell Biochem 2000; 76:651-657.
34. COSTA EJX, SHIDA CS, BIAGGI MH, ITO AS, LAMY-FREUND MT. How melatonin interacts with lipid bilayers: a study by fluorescence and ESR spectroscopies. FEBS Lett 1997; 416:103-106.
35. SAKOTNIK A, LIEBMANN PM, STOSCHITZKY K et al. Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J 1999; 20:1314-1317.
36. BRUSCO LI, MARQUEZ M, CARDINALI DP. Monozygotic twins with Alzheimer's disease treated with melatonin: Case report. J Pineal Res 1998; 25:260-263.
37. GITTO E, KARBOWNIK M, REITER RJ et al. Effects of melatonin treatment in septic newborns. Pediat Res 2001; 50:756-760.
38. FULIA F, GITTO E, CUZZOCREA S et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001; 31:343-349.